Scotts Miracle-Gro [SMG] vs ICL [ICL] Detailed Stock Comparison
Scotts Miracle-Gro
NYSE
Loading...
ICL
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Scotts Miracle-Gro wins in 12 metrics, ICL wins in 8 metrics, with 0 ties. Scotts Miracle-Gro appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Scotts Miracle-Gro | ICL | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 75.76 | 21.23 | ICL |
| Price-to-Book Ratio | -20.61 | 1.45 | Scotts Miracle-Gro |
| Debt-to-Equity Ratio | -14.48 | 39.62 | Scotts Miracle-Gro |
| PEG Ratio | 7.06 | 15.67 | Scotts Miracle-Gro |
| EV/EBITDA | 11.78 | 8.50 | ICL |
| Profit Margin (TTM) | 1.54% | 5.66% | ICL |
| Operating Margin (TTM) | 19.49% | 10.47% | Scotts Miracle-Gro |
| EBITDA Margin (TTM) | 19.49% | 10.47% | Scotts Miracle-Gro |
| Return on Equity | 8.93% | 7.30% | Scotts Miracle-Gro |
| Return on Assets (TTM) | 8.31% | 4.15% | Scotts Miracle-Gro |
| Free Cash Flow (TTM) | $583.50M | $755.00M | ICL |
| Dividend Yield | 3.25% | 0.74% | Scotts Miracle-Gro |
| 1-Year Return | -14.96% | 41.46% | ICL |
| Price-to-Sales Ratio (TTM) | 1.04 | 1.25 | Scotts Miracle-Gro |
| Enterprise Value | $6.05B | $10.76B | ICL |
| EV/Revenue Ratio | 1.76 | 1.57 | ICL |
| Gross Profit Margin (TTM) | 31.82% | 31.69% | Scotts Miracle-Gro |
| Revenue per Share (TTM) | $60 | $5 | Scotts Miracle-Gro |
| Earnings per Share (Diluted) | $0.82 | $0.31 | Scotts Miracle-Gro |
| Beta (Stock Volatility) | 1.94 | 1.18 | ICL |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Scotts Miracle-Gro vs ICL Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Scotts Miracle-Gro | -1.74% | -4.24% | -8.72% | -2.90% | -2.97% | -7.11% |
| ICL | -0.80% | 1.97% | -9.34% | -5.48% | -0.32% | 25.20% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Scotts Miracle-Gro | -14.96% | -15.95% | -63.63% | -3.22% | 25.29% | 50.83% |
| ICL | 41.46% | -42.18% | 65.60% | 8.95% | -51.29% | 65.60% |
Performance & Financial Health Analysis: Scotts Miracle-Gro vs ICL
| Metric | SMG | ICL |
|---|---|---|
| Market Information | ||
| Market Cap | $3.59B | $8.62B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 673,207 | 926,070 |
| 90 Day Avg. Volume | 831,289 | 784,987 |
| Last Close | $61.04 | $6.21 |
| 52 Week Range | $45.61 - $93.90 | $3.79 - $7.35 |
| % from 52W High | -34.99% | -15.51% |
| All-Time High | $254.34 (Apr 05, 2021) | $26.00 (Jun 16, 2008) |
| % from All-Time High | -76.00% | -76.12% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.01% | 0.02% |
| Quarterly Earnings Growth | 0.13% | -0.17% |
| Financial Health | ||
| Profit Margin (TTM) | 0.02% | 0.06% |
| Operating Margin (TTM) | 0.19% | 0.10% |
| Return on Equity (TTM) | 0.09% | 0.07% |
| Debt to Equity (MRQ) | -14.48 | 39.62 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $-2.96 | $4.53 |
| Cash per Share (MRQ) | $0.90 | $0.34 |
| Operating Cash Flow (TTM) | $315.70M | $1.34B |
| Levered Free Cash Flow (TTM) | $224.75M | $476.12M |
| Dividends | ||
| Last 12-Month Dividend Yield | 3.25% | 0.74% |
| Last 12-Month Dividend | $1.98 | $0.05 |
Valuation & Enterprise Metrics Analysis: Scotts Miracle-Gro vs ICL
| Metric | SMG | ICL |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 75.76 | 21.23 |
| Forward P/E | 14.65 | 15.67 |
| PEG Ratio | 7.06 | 15.67 |
| Price to Sales (TTM) | 1.04 | 1.25 |
| Price to Book (MRQ) | -20.61 | 1.45 |
| Market Capitalization | ||
| Market Capitalization | $3.59B | $8.62B |
| Enterprise Value | $6.05B | $10.76B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.76 | 1.57 |
| Enterprise to EBITDA | 11.78 | 8.50 |
| Risk & Other Metrics | ||
| Beta | 1.94 | 1.18 |
| Book Value per Share (MRQ) | $-2.96 | $4.53 |
Financial Statements Comparison: Scotts Miracle-Gro vs ICL
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | SMG | ICL |
|---|---|---|
| Revenue/Sales | $1.42B | $1.77B |
| Cost of Goods Sold | $873.10M | $1.21B |
| Gross Profit | $547.90M | $560.00M |
| Research & Development | $9.10M | $18.00M |
| Operating Income (EBIT) | $355.40M | $185.00M |
| EBITDA | $367.20M | $361.00M |
| Pre-Tax Income | $300.90M | $148.00M |
| Income Tax | $83.40M | $42.00M |
| Net Income (Profit) | $217.50M | $106.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | SMG | ICL |
|---|---|---|
| Cash & Equivalents | $16.90M | $327.00M |
| Total Current Assets | $1.73B | $3.59B |
| Total Current Liabilities | $1.01B | $2.33B |
| Long-Term Debt | $2.49B | $1.91B |
| Total Shareholders Equity | $-290.10M | $5.99B |
| Retained Earnings | $373.70M | $5.76B |
| Property, Plant & Equipment | N/A | $4.03B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | SMG | ICL |
|---|---|---|
| Operating Cash Flow | $175.90M | $397.00M |
| Capital Expenditures | $-8.30M | $-267.00M |
| Free Cash Flow | $179.80M | $185.00M |
| Debt Repayment | $-260.40M | $-384.00M |
| Common Stock Repurchase | $-2.70M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | SMG | ICL |
|---|---|---|
| Shares Short | 3.59M | 1.70M |
| Short Ratio | 4.25 | 2.39 |
| Short % of Float | 0.08% | 0.00% |
| Average Daily Volume (10 Day) | 673,207 | 926,070 |
| Average Daily Volume (90 Day) | 831,289 | 784,987 |
| Shares Outstanding | 57.10M | 1.29B |
| Float Shares | 43.99M | 723.27M |
| % Held by Insiders | 0.24% | 0.44% |
| % Held by Institutions | 0.79% | 0.24% |
Dividend Analysis & Yield Comparison: Scotts Miracle-Gro vs ICL
| Metric | SMG | ICL |
|---|---|---|
| Last 12-Month Dividend | $1.98 | $0.05 |
| Last 12-Month Dividend Yield | 3.25% | 0.74% |
| 3-Year Avg Annual Dividend | $2.20 | $0.61 |
| 3-Year Avg Dividend Yield | 1.01% | 1.94% |
| 3-Year Total Dividends | $6.60 | $1.83 |
| Ex-Dividend Date | Feb 21, 2025 | Sep 04, 2024 |